[go: up one dir, main page]

NO983819D0 - Eventuelt substituerte 8-cyan-1-cyklopropyl-7-(2,8-diazabicyklo-(4.3.0)-nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-kinolinkarboksylsyrer og deres derivater - Google Patents

Eventuelt substituerte 8-cyan-1-cyklopropyl-7-(2,8-diazabicyklo-(4.3.0)-nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-kinolinkarboksylsyrer og deres derivater

Info

Publication number
NO983819D0
NO983819D0 NO983819A NO983819A NO983819D0 NO 983819 D0 NO983819 D0 NO 983819D0 NO 983819 A NO983819 A NO 983819A NO 983819 A NO983819 A NO 983819A NO 983819 D0 NO983819 D0 NO 983819D0
Authority
NO
Norway
Prior art keywords
oxo
methyl
optionally substituted
alkyl
represents hydrogen
Prior art date
Application number
NO983819A
Other languages
English (en)
Other versions
NO311521B1 (no
NO983819L (no
Inventor
Stefan Bartel
Thomas Jaetsch
Thomas Himmler
Hans-Georg Rast
Werner Hallenbach
Ernst Heinen
Franz Pirro
Martin Scheer
Michael Stegemann
Hans-Peter Stupp
Heinz-Georg Wetzstein
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19633805A external-priority patent/DE19633805A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO983819L publication Critical patent/NO983819L/no
Publication of NO983819D0 publication Critical patent/NO983819D0/no
Publication of NO311521B1 publication Critical patent/NO311521B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19983819A 1996-02-23 1998-08-20 Eventuelt substituerte 8-cyan-1-cyklopropyl-7-(2,8- diazabicyklo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-kinolinkarboksylsyrer og deres derivater, fremgangsmåte forfremstilling derav, anvendelse av forbindelsene samt legemiddelinnehold NO311521B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19606762 1996-02-23
DE19633805A DE19633805A1 (de) 1996-02-23 1996-08-22 Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
PCT/EP1997/000637 WO1997031001A1 (de) 1996-02-23 1997-02-12 Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate

Publications (3)

Publication Number Publication Date
NO983819L NO983819L (no) 1998-08-20
NO983819D0 true NO983819D0 (no) 1998-08-20
NO311521B1 NO311521B1 (no) 2001-12-03

Family

ID=26023165

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19983819A NO311521B1 (no) 1996-02-23 1998-08-20 Eventuelt substituerte 8-cyan-1-cyklopropyl-7-(2,8- diazabicyklo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-kinolinkarboksylsyrer og deres derivater, fremgangsmåte forfremstilling derav, anvendelse av forbindelsene samt legemiddelinnehold
NO2011022C NO2011022I2 (no) 1996-02-23 2011-10-02 Pradofloksacin, dets farmasøytiske akseptable hydrater og syreaddisjonssalter så vel som alkall-, jordalkall-, sølvog guanidiniumsalter

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2011022C NO2011022I2 (no) 1996-02-23 2011-10-02 Pradofloksacin, dets farmasøytiske akseptable hydrater og syreaddisjonssalter så vel som alkall-, jordalkall-, sølvog guanidiniumsalter

Country Status (22)

Country Link
US (2) US6323213B1 (no)
EP (1) EP0882049B1 (no)
JP (1) JP4338217B2 (no)
CN (2) CN1073112C (no)
AT (1) ATE228130T1 (no)
AU (1) AU715341B2 (no)
BR (1) BR9707606B1 (no)
CA (1) CA2247020C (no)
CZ (1) CZ291251B6 (no)
DE (1) DE59708771D1 (no)
DK (1) DK0882049T3 (no)
ES (1) ES2184060T3 (no)
HU (1) HU228036B1 (no)
IL (1) IL125444A (no)
NO (2) NO311521B1 (no)
NZ (1) NZ331468A (no)
PL (1) PL186737B1 (no)
PT (1) PT882049E (no)
RU (1) RU2173318C2 (no)
SK (1) SK284542B6 (no)
TR (1) TR199801493T2 (no)
WO (1) WO1997031001A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19717231A1 (de) * 1997-04-24 1998-10-29 Bayer Ag 3-Cyano-2,4,5-trifluor-benzoylfluorid
DE19733243A1 (de) * 1997-08-01 1999-02-04 Bayer Ag Verfahren zur Herstellung von 3-Cyano-2,4-dihalogen-5-fluor-benzoesäure
DE19826050A1 (de) * 1998-06-12 1999-12-16 Bayer Ag Verfahren zur Herstellung von Chinolon- und Naphthyridoncarbonsäuren und deren Ester
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE19908448A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
RU2353621C2 (ru) * 2003-04-07 2009-04-27 Силин Фармасьютикалз, Инк. Замещенные аналоги хинобензоксазина
DE10337191A1 (de) 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
SI1675852T1 (sl) * 2003-09-22 2009-06-30 Janssen Pharmaceutica Nv 7-amino alkilidenil-heterociklični kinoloni in naftiridoni
EP1669354B1 (en) 2003-09-29 2013-03-20 Daiichi Sankyo Company, Limited 8-cyanoquinolonecarboxylic acid derivative
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7759362B2 (en) 2004-04-21 2010-07-20 Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
CN1244582C (zh) * 2004-04-21 2006-03-08 中国医学科学院医药生物技术研究所 喹诺酮羧酸类化合物及其制备方法和医药用途
RU2257386C1 (ru) * 2004-05-05 2005-07-27 Пермский государственный университет 20-ароил-12-гидрокси-17,17-диметил-3-фенил-3,10,13- триазапентацикло[10.7.1.01,10.04,9.014,19]эйкоза-4,6,8,14(19)-тетраен- 2,11,15- трионы и способ их получения
DK1762844T3 (en) * 2004-06-28 2014-12-15 Chugoku Electric Power A method of testing a denitreringskatalysator
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
WO2008059521A2 (en) * 2006-11-14 2008-05-22 Msn Laboratories Limited Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin
CN101020658B (zh) * 2007-02-14 2010-12-15 杭州师范学院 喹诺酮主环化合物的合成方法
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
EA201101564A1 (ru) 2009-05-15 2012-07-30 Редкс Фарма Лимитед Редокс производные лекарственных средств
CN102603531B (zh) * 2012-02-22 2014-04-02 仙居县力天化工有限公司 一种串联法制备2,3,4,5-四氟苯甲酸甲酯的方法
KR20150036022A (ko) 2012-07-13 2015-04-07 솔베이(소시에떼아노님) 삼중 결합을 포함한 플루오르화 카보닐 화합물, 및 그의 제조 방법과 용도
WO2018146194A1 (en) 2017-02-13 2018-08-16 Bayer Animal Health Gmbh Liquid composition containing pradofloxacin
CN107987074B (zh) * 2017-10-27 2020-12-29 浙江美诺华药物化学有限公司 一种普拉沙星的合成方法
PE20201257A1 (es) 2018-04-25 2020-11-16 Bayer Animal Health Gmbh Proceso para la hidrolisis de esteres carboxilicos de quinolona
CN112881542B (zh) * 2020-10-28 2022-11-18 上海安谱实验科技股份有限公司 一种稳定同位素氘标记的达氟沙星及其合成方法
CN114716373B (zh) * 2022-04-14 2023-01-10 内蒙古源宏精细化工有限公司 一种加替沙星环合酯的制备方法
CN116813614A (zh) * 2023-05-31 2023-09-29 天津大学 一种盐酸普拉沙星二水合物晶体及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5140033A (en) 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
US5252734A (en) * 1989-04-03 1993-10-12 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
DE4123918A1 (de) * 1991-07-19 1993-01-21 Bayer Ag 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren
NO301165B1 (no) * 1992-12-25 1997-09-22 Daiichi Seiyaku Co Bicykliske aminderivater og antibakterielle midler inneholdende disse

Also Published As

Publication number Publication date
AU715341B2 (en) 2000-01-20
NO2011022I2 (no) 2013-02-18
DK0882049T3 (da) 2003-03-03
ES2184060T3 (es) 2003-04-01
PL328577A1 (en) 1999-02-01
US6323213B1 (en) 2001-11-27
ATE228130T1 (de) 2002-12-15
CN1335301A (zh) 2002-02-13
NZ331468A (en) 2000-02-28
BR9707606B1 (pt) 2010-08-10
AU1768997A (en) 1997-09-10
EP0882049A1 (de) 1998-12-09
JP4338217B2 (ja) 2009-10-07
DE59708771D1 (de) 2003-01-02
CZ268498A3 (cs) 1999-02-17
NO311521B1 (no) 2001-12-03
HUP9900502A2 (hu) 1999-06-28
RU2173318C2 (ru) 2001-09-10
CN1211984A (zh) 1999-03-24
NO983819L (no) 1998-08-20
SK114698A3 (en) 1999-01-11
IL125444A0 (en) 1999-03-12
PL186737B1 (pl) 2004-02-27
CZ291251B6 (cs) 2003-01-15
HUP9900502A3 (en) 2000-02-28
EP0882049B1 (de) 2002-11-20
HU228036B1 (en) 2012-08-28
CN1073112C (zh) 2001-10-17
CA2247020C (en) 2005-11-08
WO1997031001A1 (de) 1997-08-28
SK284542B6 (sk) 2005-06-02
HK1018903A1 (en) 2000-01-07
JP2000504734A (ja) 2000-04-18
PT882049E (pt) 2003-04-30
NO2011022I1 (no) 2011-10-17
BR9707606A (pt) 1999-07-27
US6278013B1 (en) 2001-08-21
TR199801493T2 (xx) 1998-10-21
CA2247020A1 (en) 1997-08-28
IL125444A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
NO983819D0 (no) Eventuelt substituerte 8-cyan-1-cyklopropyl-7-(2,8-diazabicyklo-(4.3.0)-nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-kinolinkarboksylsyrer og deres derivater
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
MXPA04000577A (es) Derivados de dolastatina 10.
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
MY138478A (en) Benzazepine derivatives for the treatment of neurological disorders
AP9701019A0 (en) Phenylamino-substituted tricycle derivatives.
AP2001002302A0 (en) 13-Methyl erythromycin derivatives.
NO971625L (no) Nye peptider med immunomodulatoriske effekter
SE9904129D0 (sv) Novel compounds
NO20020282L (no) Nytt difenyl-piperidinderivat
ATE277062T1 (de) Neue makrolidderivate
AP9801377A0 (en) Tricyclic erythromycin derivatives.
NO983178L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer
MXPA03007380A (es) Derivados de imidazol 2-tio sustituidos y el uso de los mismos en la industria farmaceutica.
SE9902551D0 (sv) Novel compounds
MY122142A (en) Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8- diazabicyclo[4.3.0] nonan-8-yl)-6-fluoro-1, 4-dihydro-4-oxo-3- quinolinecarboxylic acids and their derivatives
HUP0204217A2 (en) Novel a-500359 derivatives
AP9801235A0 (en) Erythromycin derivatives.
DK0767783T3 (da) Substituerede alkyldiaminderivater og deres anvendelse som tachykinin-antagonister
BRPI0410026A (pt) derivados de 3-amino-croman quinolina
FR2816942B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
MXPA02008012A (es) Derivados de 9-alquilamino-1-nitroacridina.
TH29857B (th) กรด 8-ไซยาโน-1-ไซโคลโพรพิล-7-(2,8-ไดอะชาไบไซโคล [4.3.0] โนเนน-8-อิล)-6-ฟลูออโร-1,4-ไดไฮโดร-4-ออกโซ-3-ควิโนลีนคาร์บอกซิลิคที่ถูกเข้าแทนที่แบบทางเลือกและอนุพันธ์ของมัน

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: VERAFLOX; NAT. REG. NO/DATE: EU/2/10/107/001-014 20110624; FIRST REG. NO/DATE: EU , EU/2/10/107/001-014 20110412

Spc suppl protection certif: 2011022

Filing date: 20111002

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: VERAFLOX; NAT. REG. NO/DATE: EU/2/10/107/001-014 20110624; FIRST REG. NO/DATE: EU , EU/2/10/107/001-014 20110412

Spc suppl protection certif: 2011022

Filing date: 20111002

Extension date: 20220212

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MK1K Patent expired
SPCX Expiry of an spc

Spc suppl protection certif: 2011022